Amir Abdolahi1,2, Geoffrey C Williams3, Curtis G Benesch4, Henry Z Wang5, Eric M Spitzer6, Bryan E Scott6, Robert C Block1, Edwin van Wijngaarden1. 1. Department of Public Health Sciences, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. 2. Department of Acute Care Solutions, Philips Research North America, Briarcliff Manor, NY, USA. 3. Departments of Medicine, Psychiatry, and Clinical and Social Sciences in Psychology, University of Rochester Medical Center, Rochester, NY, USA. 4. Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA. 5. Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA. 6. Department of Radiology, Rochester General Health System, Rochester, NY, USA.
Abstract
BACKGROUND AND AIMS: Current pharmacotherapies for tobacco dependence are generally well tolerated, but have relatively high rates of relapse. They target primarily the brains' mesocorticolimbic 'reward' pathway. However, recent evidence suggests that the insular cortex, a central cerebral hemispheric region historically overlooked in addiction models, may also play an important role in cognitive and emotional processes that facilitate drug use. We examined whether insular versus non-insular damage from ischemic stroke attenuated acute withdrawal from cigarette smoking and reduced the likelihood of nicotine replacement therapy (NRT) use during hospitalization. DESIGN: Data were derived from a longitudinal study with 3 months' follow-up, beginning June 2013 and ending May 2014. SETTING: Three acute care hospitals in Rochester, NY, USA. PARTICIPANTS: One-hundred and fifty-six current smokers hospitalized for acute ischemic stroke (38 with insular infarctions and 118 with non-insular infarctions, assessed by three neuroradiologists). MEASUREMENTS: The Wisconsin Smoking Withdrawal Scale (WSWS) and Minnesota Nicotine Withdrawal Scale (MNWS) were administered during hospitalization (a period of forced abstinence) to assess the frequency and severity of withdrawal symptoms. NRT use was also assessed during hospitalization. FINDINGS: On average, smokers with insular damage had a lower WSWS score during admission [mean=5.89, standard deviation (SD)=4.72] compared with those with non-insular damage (mean=9.20, SD=4.71; P<0.001) [covariate-adjusted difference in means of -3.12, 95% confidence interval (CI)=-4.97, -1.27]. A similar difference was also noted when the MNWS was used (P=0.02). Furthermore, participants with insular lesions appeared to be less likely to use NRT during admission compared with those with non-insular lesions [odds ratio (OR)=0.72, 95% CI=0.32, 1.64]. CONCLUSIONS: Current smokers with damage to their insular cortex brain region appear to experience fewer and less severe tobacco withdrawal symptoms, and appear to be less likely to require nicotine replacement therapy during hospitalization, compared with smokers with non-insular damage. These findings support the potential role of the insular cortex in regulating withdrawal during abstinence, a motivator responsible for the maintenance of addictive behaviors.
BACKGROUND AND AIMS: Current pharmacotherapies for tobacco dependence are generally well tolerated, but have relatively high rates of relapse. They target primarily the brains' mesocorticolimbic 'reward' pathway. However, recent evidence suggests that the insular cortex, a central cerebral hemispheric region historically overlooked in addiction models, may also play an important role in cognitive and emotional processes that facilitate drug use. We examined whether insular versus non-insular damage from ischemic stroke attenuated acute withdrawal from cigarette smoking and reduced the likelihood of nicotine replacement therapy (NRT) use during hospitalization. DESIGN: Data were derived from a longitudinal study with 3 months' follow-up, beginning June 2013 and ending May 2014. SETTING: Three acute care hospitals in Rochester, NY, USA. PARTICIPANTS: One-hundred and fifty-six current smokers hospitalized for acute ischemic stroke (38 with insular infarctions and 118 with non-insular infarctions, assessed by three neuroradiologists). MEASUREMENTS: The Wisconsin Smoking Withdrawal Scale (WSWS) and Minnesota Nicotine Withdrawal Scale (MNWS) were administered during hospitalization (a period of forced abstinence) to assess the frequency and severity of withdrawal symptoms. NRT use was also assessed during hospitalization. FINDINGS: On average, smokers with insular damage had a lower WSWS score during admission [mean=5.89, standard deviation (SD)=4.72] compared with those with non-insular damage (mean=9.20, SD=4.71; P<0.001) [covariate-adjusted difference in means of -3.12, 95% confidence interval (CI)=-4.97, -1.27]. A similar difference was also noted when the MNWS was used (P=0.02). Furthermore, participants with insular lesions appeared to be less likely to use NRT during admission compared with those with non-insular lesions [odds ratio (OR)=0.72, 95% CI=0.32, 1.64]. CONCLUSIONS: Current smokers with damage to their insular cortex brain region appear to experience fewer and less severe tobaccowithdrawal symptoms, and appear to be less likely to require nicotine replacement therapy during hospitalization, compared with smokers with non-insular damage. These findings support the potential role of the insular cortex in regulating withdrawal during abstinence, a motivator responsible for the maintenance of addictive behaviors.
Authors: Varun Sethi; Tarek A Yousry; Nils Muhlert; Maria Ron; Xavier Golay; Claudia Wheeler-Kingshott; David H Miller; Declan T Chard Journal: J Neurol Neurosurg Psychiatry Date: 2012-07-17 Impact factor: 10.154
Authors: Angelo Del Parigi; Jean-Francois Gautier; Kewei Chen; Arline D Salbe; Eric Ravussin; Eric Reiman; P Antonio Tataranni Journal: Ann N Y Acad Sci Date: 2002-06 Impact factor: 5.691
Authors: Samuel W Centanni; Bridget D Morris; Joseph R Luchsinger; Gaurav Bedse; Tracy L Fetterly; Sachin Patel; Danny G Winder Journal: Neuropsychopharmacology Date: 2018-11-02 Impact factor: 7.853
Authors: Amir Abdolahi; Geoffrey C Williams; Curtis G Benesch; Henry Z Wang; Eric M Spitzer; Bryan E Scott; Robert C Block; Edwin van Wijngaarden Journal: Addict Behav Date: 2015-07-06 Impact factor: 3.913
Authors: John R Fedota; Xiaoyu Ding; Allison L Matous; Betty Jo Salmeron; Michael R McKenna; Hong Gu; Thomas J Ross; Elliot A Stein Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2017-10-10